Gout Disease Treatment Market Size, Share, Growth Report 2032
Gout Disease Treatment Market - By Conditional Stage (Acute Gout and Chronic Gout), Therapeutic (Urate-Lowering Therapies, Inflammatory), Product (Colchicine, Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2764.89 Million | USD 5527.03 Million | 8.00% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1.Report Description
- 1.1.Report Scope
- Chapter 2.Research Methodology
- 2.1.Research Methodology
- 2.2.Secondary Research
- 2.3.Primary Research
- 2.4.Models
- 2.4.1.Company Share Analysis Model
- 2.4.2.Revenue Based Modeling
- 2.5.Research Limitations
- Chapter 3.Executive Summary
- 3.1.Global Gout Disease Treatment Market, 2024 – 2032 (USD Million)
- 3.2.Global Gout Disease Treatment Market: Snapshot
- Chapter 4.Gout Disease Treatment Market – Industry Analysis
- 4.1.Introduction
- 4.2.Market Drivers
- 4.2.1.Driving Factor 1 Analysis
- 4.2.2.Driving Factor 2 Analysis:
- 4.3.Market Restraints
- 4.3.1.Restraining Factor Analysis
- 4.4.Market Opportunities
- 4.4.1.Market Opportunity & Use-case Analysis
- 4.4.2.Use – Cases for Gout Disease Treatment
- 4.5.Porter’s Five Forces Analysis
- 4.6.COVID-19 Impact Analysis
- 4.6.1.1.Impact on Product Development and Technology Adoption
- 4.6.1.2.Gap Analysis
- Chapter 5.Investment Proposition Analysis
- 5.1.Global Gout Disease Treatment Market Attractiveness, By Conditional Stage
- 5.2.Global Gout Disease Treatment Market Attractiveness, By Therapeutic
- 5.3.Global Gout Disease Treatment Market Attractiveness, By Product
- 5.4.Global Gout Disease Treatment Market Attractiveness, By Region
- Chapter 6.Competitive Landscape
- 6.1.Company Market Share Analysis - 2024
- 6.1.1.Global Gout Disease Treatment Market: Company Market Share, 2024
- 6.2.Strategic Developments
- 7.1.Global Gout Disease Treatment Market Overview: by Conditional Stage
- 7.1.1.Global Gout Disease Treatment Market Revenue Share, by Conditional Stage, 2024 & 2032
- 7.2.Global Gout Disease Treatment Market Analysis/Overview – By Conditional Stage
- 7.2.1.Acute Gout – Overview/Analysis
- 7.2.2.Chronic Gout – Overview/Analysis
- 7.3.Acute Gout
- 7.3.1.Global Gout Disease Treatment Market for Acute Gout, Revenue (USD Million) 2024 - 2032
- 7.4.Chronic Gout
- 7.4.1.Global Gout Disease Treatment Market for Chronic Gout, Revenue (USD Million) 2024 - 2032
- 8.1.Global Gout Disease Treatment Market Overview: by Therapeutic
- 8.1.1.Global Gout Disease Treatment Market Revenue Share, by Therapeutic, 2024 & 2032
- 8.2.Global Gout Disease Treatment Market Analysis/Overview – By Therapeutic
- 8.2.1.Urate-Lowering Therapies – Overview/Analysis
- 8.2.2.Inflammatory – Overview/Analysis
- 8.3.Urate-Lowering Therapies
- 8.3.1.Global Gout Disease Treatment Market for Urate-Lowering Therapies, Revenue (USD Million) 2024 - 2032
- 8.4.Inflammatory
- 8.4.1.Global Gout Disease Treatment Market for Inflammatory, Revenue (USD Million) 2024 - 2032
- 9.1.Global Gout Disease Treatment Market Overview: by Product
- 9.1.1.Global Gout Disease Treatment Market Revenue Share, by Product, 2024 & 2032
- 9.2.Global Gout Disease Treatment Market Analysis/Overview – By Product
- 9.2.1.Culchicine – Overview/Analysis
- 9.2.2.Non-steroidal Anti-Inflammatory Drugs (NSAIDs) – Overview/Analysis
- 9.2.3.Corticosteroids – Overview/Analysis
- 9.3.Culchicine
- 9.3.1.Global Gout Disease Treatment Market for Culchicine, Revenue (USD Million) 2024 - 2032
- 9.4.Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
- 9.4.1.Global Gout Disease Treatment Market for Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Revenue (USD Million) 2024 - 2032
- 9.5.Corticosteroids
- 9.5.1.Global Gout Disease Treatment Market for Corticosteroids, Revenue (USD Million) 2024 - 2032
- 6.1.Company Market Share Analysis - 2024
- Chapter 10.Gout Disease Treatment Market – Regional Analysis
- 10.1.Global Gout Disease Treatment Market: Regional Overview
- 10.1.1.Global Gout Disease Treatment Market Revenue Share, by Region, 2024 & 2032
- 10.1.2.Global Gout Disease Treatment Market Revenue, by Region, 2024 – 2032 (USD Million)
- 10.2.North America
- 10.2.1.North America Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
- 10.2.2.North America Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
- 10.2.3.North America Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032
- 10.2.4.North America Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032
- 10.2.5.North America Gout Disease Treatment Market Revenue, by Product, 2024 – 2032
- 10.2.6. U.S.
- 10.2.7.Canada
- 10.3.Europe
- 10.3.1.Europe Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
- 10.3.2.Europe Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
- 10.3.3.Europe Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032
- 10.3.4.Europe Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032
- 10.3.5.Europe Gout Disease Treatment Market Revenue, by Product, 2024 – 2032
- 10.3.6.Germany
- 10.3.7.France
- 10.3.8. U.K.
- 10.3.9.Italy
- 10.3.10.Spain
- 10.3.11.Rest of Europe
- 10.4.Asia Pacific
- 10.4.1.Asia Pacific Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
- 10.4.2.Asia Pacific Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
- 10.4.3.Asia Pacific Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032
- 10.4.4.Asia Pacific Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032
- 10.4.5.Asia Pacific Gout Disease Treatment Market Revenue, by Product, 2024 – 2032
- 10.4.6.China
- 10.4.7.Japan
- 10.4.8.India
- 10.4.9.South Korea
- 10.4.10.South-East Asia
- 10.4.11.Rest of Asia Pacific
- 10.5.Latin America
- 10.5.1.Latin America Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
- 10.5.2.Latin America Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
- 10.5.3.Latin America Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032
- 10.5.4.Latin America Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032
- 10.5.5.Latin America Gout Disease Treatment Market Revenue, by Product, 2024 – 2032
- 10.5.6.Brazil
- 10.5.7.Mexico
- 10.5.8.Rest of Latin America
- 10.6.The Middle-East and Africa
- 10.6.1.The Middle-East and Africa Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
- 10.6.2.The Middle-East and Africa Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
- 10.6.3.The Middle-East and Africa Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032
- 10.6.4.The Middle-East and Africa Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032
- 10.6.5.The Middle-East and Africa Gout Disease Treatment Market Revenue, by Product, 2024 – 2032
- 10.6.6.GCC Countries
- 10.6.7.South Africa
- 10.6.8.Rest of Middle-East Africa
- 10.1.Global Gout Disease Treatment Market: Regional Overview
- Chapter 11.Company Profiles
- 11.1.Novartis AG
- 11.1.1.Company Overview
- 11.1.2.Financial Overview
- 11.1.3.Product Portfolio
- 11.1.4.Business Strategy
- 11.1.5.Recent Developments
- 11.2.AstraZeneca PLC
- 11.3.Pularis Group
- 11.4.Teijin Pharma Limited
- 11.5.BioCryst Pharmaceuticals Inc.
- 11.6.Nippon Chemiphar Co. Ltd
- 11.7.JW Pharmaceutical Corporation
- 11.1.Novartis AG
Table Of Figures
List of Figures
FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Gout Disease Treatment Market
FIG. 6 Global Gout Disease Treatment Market Attractiveness, By Conditional Stage
FIG. 7 Global Gout Disease Treatment Market Attractiveness, By Therapeutic
FIG. 8 Global Gout Disease Treatment Market Attractiveness, By Product
FIG. 9 Global Gout Disease Treatment Market Attractiveness, By End-User
FIG. 10 Company Share Analysis, 2024
FIG. 11 Global Gout Disease Treatment Market Revenue Share, by Conditional Stage, 2024 & 2032
FIG. 12 Global Gout Disease Treatment Market for Acute Gout, Revenue (USD Million) 2024 - 2032
FIG. 13 Global Gout Disease Treatment Market for Chronic Gout, Revenue (USD Million) 2024 - 2032
FIG. 14 Global Gout Disease Treatment Market Revenue Share, by Therapeutic, 2024 & 2032
FIG. 15 Global Gout Disease Treatment Market for Urate-Lowering Therapies, Revenue (USD Million) 2024 - 2032
FIG. 16 Global Gout Disease Treatment Market for Inflammatory, Revenue (USD Million) 2024 - 2032
FIG. 17 Global Gout Disease Treatment Market Revenue Share, by Product, 2024 & 2032
FIG. 18 Global Gout Disease Treatment Market for Colchicine, Revenue (USD Million) 2024 - 2032
FIG. 19 Global Gout Disease Treatment Market for Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Revenue (USD Million) 2024 - 2032
FIG. 20 Global Gout Disease Treatment Market for Corticosteroids, Revenue (USD Million) 2024 - 2032
FIG. 21 Global Gout Disease Treatment Market Revenue Share, by Region, 2024 & 2032
FIG. 22 North America Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 23 Europe Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 24 Asia Pacific Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 25 Latin America Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 26 The Middle-East and Africa Gout Disease Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 27 Novartis AG Business Segment Revenue Share, 2024 (%)
FIG. 28 Novartis AG Geographical Segment Revenue Share, 2024 (%)
Table Of Tables
List of Tables
TABLE 1 Global Gout Disease Treatment Market: Snapshot
TABLE 2 Drivers of the Gout Disease Treatment Market: Impact Analysis
TABLE 3 Restraints for the Gout Disease Treatment Market: Impact Analysis
TABLE 4 Global Gout Disease Treatment Market Revenue, by Region, 2024 – 2032 (USD Million)
TABLE 5 North America Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 6 North America Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032 (USD Million)
TABLE 7 North America Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032 (USD Million)
TABLE 8 North America Gout Disease Treatment Market Revenue, by Product, 2024 – 2032 (USD Million)
TABLE 9 Europe Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 10 Europe Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032 (USD Million)
TABLE 11 Europe Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032 (USD Million)
TABLE 12 Europe Gout Disease Treatment Market Revenue, by Product, 2024 – 2032 (USD Million)
TABLE 13 Asia Pacific Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 14 Asia Pacific Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032 (USD Million)
TABLE 15 Asia Pacific Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032 (USD Million)
TABLE 16 Asia Pacific Gout Disease Treatment Market Revenue, by Product, 2024 – 2032 (USD Million)
TABLE 17 Latin America Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 18 Latin America Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032 (USD Million)
TABLE 19 Latin America Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032 (USD Million)
TABLE 20 Latin America Gout Disease Treatment Market Revenue, by Product, 2024 – 2032 (USD Million)
TABLE 21 The Middle-East and Africa Gout Disease Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 22 The Middle-East and Africa Gout Disease Treatment Market Revenue, by Conditional Stage, 2024 – 2032 (USD Million)
TABLE 23 The Middle-East and Africa Gout Disease Treatment Market Revenue, by Therapeutic, 2024 – 2032 (USD Million)
TABLE 24 The Middle-East and Africa Gout Disease Treatment Market Revenue, by Product, 2024 – 2032 (USD Million)
Methodology
FrequentlyAsked Questions
Gout, a painful type of arthritis, results from a buildup of uric acid crystals in the joints. There are effective treatment options to manage this condition. Firstly, during a gout attack, medications like nonsteroidal anti-inflammatory drugs (NSAIDs) target pain and swelling to bring you quick relief. Colchicine and corticosteroids may also be used in specific cases. Once the initial flare-up subsides, the focus shifts to preventing future attacks. This involves medications like allopurinol or febuxostat that lower uric acid levels in the blood, essentially reducing the fuel for future crystal formation. Additionally, adopting a healthy lifestyle with a focus on weight management, avoiding certain foods high in purines, and staying well-hydrated all play a crucial role in keeping gout under control.
According to a study, the global gout disease treatment market size was worth around USD 2764.89 million in 2023 and is expected to reach USD 5527.03 million by 2032.
The global gout disease treatment market is expected to grow at a CAGR of 8.00% during the forecast period.
North America is expected to dominate the gout disease treatment market over the forecast period.
Leading players in the global gout disease treatment market include Novartis AG, AstraZeneca PLC, Polaris Group, Teijin Pharma Limited, BioCryst Pharmaceuticals, Inc., Nippon Chemiphar Co., Ltd., JW Pharmaceutical Corporation, Addex Therapeutics, Takeda Pharmaceutical Company, LG Life Sciences Ltd., Pfizer, and Merck, among others.
The gout disease treatment market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
Choose License Type
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed